Hello!

This fund has just been established, and it is still unclear how well it will operate.

At this stage, this fund has not opened any positions. It seems that it is not optimistic about the recent market and is still waiting for a better opportunity.

The overall strength of Southern Fund is relatively good, and the fund manager’s resume is also very good. He is a professional in the pharmaceutical industry and an experienced investor. It seems that it should be good, but it has not been put into operation. Everything is just talk on paper without verification.

, it is recommended to observe it.

Fund manager resume: Master of Medicine from the Third Military Medical University, with fund practitioner qualification.

He once served as the attending physician of the Department of Surgery at Tianjin 272 Hospital, the director of the marketing department of Shenzhen Jian'an Pharmaceuticals, and the director of the academic promotion department of Zhongxin Pharmaceutical's patent medicine branch; from April 2002 to August 2008, he successively served as a researcher at the Ping An Securities Research Institute and a chief researcher in the pharmaceutical industry.

, deputy general manager of the industry department.

He joined Southern Fund in September 2008 and served as chief researcher of the pharmaceutical industry and leader of the consumer group in the research department; from March 2012 to present, he served as manager of Southern Consumer Fund.

I am still very optimistic about this pharmaceutical industry, which is in urgent demand, and as the aging population intensifies, the development prospects are promising. At this stage, my first choice is China Universal Pharmaceuticals and Rongtong Medical, which have proven their actual operation and have stable and excellent long-term performance.

As for the southern one, if you are confident, there is no harm in choosing it.